| 000 | 01364 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517100752.0 | ||
| 264 | 0 | _c20170404 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a1878-3686 | ||
| 024 | 7 |
_a10.1016/j.ccell.2016.05.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDahan, Rony | |
| 245 | 0 | 0 |
_aTherapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement. _h[electronic resource] |
| 260 |
_bCancer cell _c06 2016 |
||
| 300 |
_a820-831 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
| 650 | 0 | 4 |
_aCD40 Antigens _xagonists |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aReceptors, IgG _ximmunology |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aBarnhart, Bryan C | |
| 700 | 1 | _aLi, Fubin | |
| 700 | 1 | _aYamniuk, Aaron P | |
| 700 | 1 | _aKorman, Alan J | |
| 700 | 1 | _aRavetch, Jeffrey V | |
| 773 | 0 |
_tCancer cell _gvol. 29 _gno. 6 _gp. 820-831 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ccell.2016.05.001 _zAvailable from publisher's website |
| 999 |
_c26094012 _d26094012 |
||